USD 8.27
(4.03%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 21.89 Million USD | -25.14% |
2022 | 29.24 Million USD | -70.44% |
2021 | 98.94 Million USD | 10482.46% |
2020 | 935 Thousand USD | 27.56% |
2019 | 733 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 21.27 Million USD | -2.83% |
2024 Q2 | 21.48 Million USD | 0.99% |
2023 Q2 | 28.83 Million USD | -13.56% |
2023 Q4 | 21.89 Million USD | -9.45% |
2023 Q1 | 33.36 Million USD | 14.07% |
2023 FY | 21.89 Million USD | -25.14% |
2023 Q3 | 24.17 Million USD | -16.15% |
2022 Q2 | 34.27 Million USD | -33.76% |
2022 FY | 29.24 Million USD | -70.44% |
2022 Q4 | 29.24 Million USD | -29.9% |
2022 Q1 | 51.74 Million USD | -47.71% |
2022 Q3 | 41.72 Million USD | 21.74% |
2021 FY | 98.94 Million USD | 10482.46% |
2021 Q2 | 53.06 Million USD | 18.64% |
2021 Q3 | 183.72 Million USD | 246.22% |
2021 Q1 | 44.73 Million USD | 4683.98% |
2021 Q4 | 98.94 Million USD | -46.15% |
2020 FY | 935 Thousand USD | 27.56% |
2020 Q3 | 12.2 Million USD | 0.0% |
2020 Q4 | 935 Thousand USD | -92.34% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 733 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Abbott Laboratories | 34.38 Billion USD | 99.936% |
Allurion Technologies Inc. | 142.19 Million USD | 84.603% |
Artivion, Inc. | 510.61 Million USD | 95.712% |
Avanos Medical, Inc. | 456.1 Million USD | 95.2% |
Butterfly Network, Inc. | 84.22 Million USD | 74.003% |
Butterfly Network, Inc. | 84.22 Million USD | 74.003% |
Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 99.385% |
Boston Scientific Corporation | 15.6 Billion USD | 99.86% |
CONMED Corporation | 1.46 Billion USD | 98.506% |
Edwards Lifesciences Corporation | 2.64 Billion USD | 99.172% |
Paragon 28, Inc. | 162.95 Million USD | 86.564% |
Glaukos Corporation | 478.64 Million USD | 95.426% |
Globus Medical, Inc. | 1.08 Billion USD | 97.988% |
Inspire Medical Systems, Inc. | 104.29 Million USD | 79.007% |
Integer Holdings Corporation | 1.41 Billion USD | 98.451% |
Medtronic plc | 39.56 Billion USD | 99.945% |
Myomo, Inc. | 5.59 Million USD | -291.526% |
Nevro Corp. | 330.31 Million USD | 93.371% |
Owlet, Inc. | 73.79 Million USD | 70.332% |
Penumbra, Inc. | 377.36 Million USD | 94.198% |
Smith & Nephew plc | 4.77 Billion USD | 99.541% |
STERIS plc | 4.74 Billion USD | 99.539% |
Stryker Corporation | 21.31 Billion USD | 99.897% |
Vapotherm, Inc. | 132.95 Million USD | 83.532% |
Zimmer Biomet Holdings, Inc. | 9 Billion USD | 99.757% |